tnbc hs 317 578t (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
97
Structured Review
ATCC
tnbc hs 317 578t
Tnbc Hs 317 578t, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1252 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tnbc+hs+317+578t/HCC1937/pm42093158-152-21-49
Average 97 stars, based on 1252 article reviews
Tnbc Hs 317 578t, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1252 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tnbc+hs+317+578t/HCC1937/pm42093158-152-21-49
Average 97 stars, based on 1252 article reviews
tnbc hs 317 578t - by Bioz Stars,
2026-09
97/100 stars
Images
Related Articles
Multiple Displacement Amplification:Article Title: Estrogen-mediated NF-κB blockade enables breast cancer sensitivity to oncolytic VSV virotherapy. Article Snippet: Please cite this article as: Viens M, Geoffroy K, Meuriot E, Buccilli A, Mullins-Dansereau V, Myre M-L, Paradisis S, Bardoul A, Kalin EM, Saraiva BA, Valencia J, Desaulniers KL, Hoang H-D, Hassan S, Bell JC, Vanderhyden B, Alain T, Roy DG, Cook DP, Bourgeois-Daigneault M-C, Estrogen-mediated NF-κB blockade enables breast cancer sensitivity to oncolytic VSV virotherapy, Molecular Therapy (2026), doi: https://doi.org/10.1016/j.ymthe.2026.04.061. Modification:Article Title: Estrogen-mediated NF-κB blockade enables breast cancer sensitivity to oncolytic VSV virotherapy. Article Snippet: Please cite this article as: Viens M, Geoffroy K, Meuriot E, Buccilli A, Mullins-Dansereau V, Myre M-L, Paradisis S, Bardoul A, Kalin EM, Saraiva BA, Valencia J, Desaulniers KL, Hoang H-D, Hassan S, Bell JC, Vanderhyden B, Alain T, Roy DG, Cook DP, Bourgeois-Daigneault M-C, Estrogen-mediated NF-κB blockade enables breast cancer sensitivity to oncolytic VSV virotherapy, Molecular Therapy (2026), doi: https://doi.org/10.1016/j.ymthe.2026.04.061. |